FDA Outlook for 2010

Learn about upcoming changes the medical technology and life sciences industry should expect from the FDA under the new Administration.  The webinar and podcast feature Mark DuVal, an attorney who specializes in FDA issues and trends.  Mr. DuVal identifies new FDA staff in key roles, describes possible changes to the 510(k) process, and explains how inspection and enforcement activities will change in the near future.